Skip to main content

Table 2 Prevalence (number and proportions) of the two groups of patients HFpEF and HFrEF reporting at least some problems (levels 2 or 3) for each dimension of EQ-5D at baseline and at follow up and changes between baseline and follow up

From: Evaluation of the usefulness of EQ-5D as a patient-reported outcome measure using the Paretian classification of health change among patients with chronic heart failure

 Number of patients reporting problems levels 2 and 3Change in numbers of patients reporting problems levels 2 and 3Percent change in numbers of patients reporting problems levels 2 and 3
HFpEF > 50%,HFrEF < 40%EF > 50%,EF < 40%EF > 50%,EF < 40%
Baseline % (n)Follow up % (n)p-valueBaseline % (n)Follow up % (n)p-value    
Mobility51 (473)58 (540)< 0.00136 (1396)42 (1598)< 0.001+  67+  202+  14%+  14%
Self-care13 (121)18 (163)0.0019 (341)10 (402)0.003+  42+  61+  35%+  18%
Usual activities34 (320)41 (382)< 0.00131 (1203)29 (1120)0.013+  62- 83+  19%- 7%
Pain/discomfort55 (516)66 (618)< 0.00143 (1644)52 (1990)< 0.001+  102+ 346+  20%+  21%
Anxiety/depression44 (406)48 (444)0.02540 (1525)39 (1505)0.550+  38- 20+  9,4%- 1%
EQ-5D Index (mean levels)0.710.67< 0.0010.770.760.051